Ask Sterling

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving the EV sector growth?

Companies Sectors Ask Sterling Compare

Favorites

Revenue Breakdown

Chart: Revenue Breakdown for Arcturus Therapeutics. Values in USD billions. In Q2 2026: Revenue 0.003, Gross Profit 0.003, Operating Income -0.026.

Revenue Flow

Chart: Revenue Flow for Arcturus Therapeutics. Q2 2026, values in USD. Revenue 0.003, Gross Profit 0.003, Cost of Revenue 0, Net Income -0.024, Operating Income -0.026.

Balance Sheet

Chart: Balance Sheet for Arcturus Therapeutics. Values in currency. In Q2 2026: Total Assets 0.224, Total Liabilities 0.053, Total Equity 0.172.

Q3 2016-Q2 2026

Cash Flow

Chart: Cash Flow for Arcturus Therapeutics. Values in currency. In Q2 2026: Operating Cash Flow -0.02, Free Cash Flow -0.02, Capital Expenditures 0.

Q3 2016-Q2 2026

Arcturus Therapeutics (ARCT) - Compare | Sterling

Revenue Breakdown

Chart: Revenue Breakdown for Arcturus Therapeutics. Values in USD billions. In Q2 2026: Revenue 0.003, Gross Profit 0.003, Operating Income -0.026.

Revenue Flow

Chart: Revenue Flow for Arcturus Therapeutics. Q2 2026, values in USD. Revenue 0.003, Gross Profit 0.003, Cost of Revenue 0, Net Income -0.024, Operating Income -0.026.

Balance Sheet

Chart: Balance Sheet for Arcturus Therapeutics. Values in currency. In Q2 2026: Total Assets 0.224, Total Liabilities 0.053, Total Equity 0.172.

Q3 2016-Q2 2026

Cash Flow

Chart: Cash Flow for Arcturus Therapeutics. Values in currency. In Q2 2026: Operating Cash Flow -0.02, Free Cash Flow -0.02, Capital Expenditures 0.

Q3 2016-Q2 2026